Reticuloendothelial Negative Contrast Media for Hepatocellular Carcinoma: Initial Comparison of Chondroitin Sulfate Iron Colloid and Ferrixan in Fast T2-Weighted MR Imaging

概要

論文の詳細を見る
Chondroitin sulfate iron colloid (CSIC), a paramagnetic substance, and Ferrixan (SHU555A), a superparamagnetic substance, were administered to 20 patients with 26 nodules of hepatocellular carcinoma, and the visualization of the lesions by fast T2-weighted magnetic resonance imaging (MRI) was quantitatively evaluated. Conventional spin-echo (CSE), turbo spin-echo (TSE), and turbo gradient spin-echo (TGSE) sequences were performed in all patients before and after the administration of the iron colloid preparations. The signal-to-noise ratio (SNR) in the liver decreased significantly after administration of iron colloid preparations by all sequences and at all doses. A reduction in SNR in the liver similar to that obtained with SHU555A could be obtained by increasing the dose of CSIC, which has a weaker T2-shortening effect. In the TSE sequence with a weaker susceptibility effect, the decrease in SNR in the liver tended to be equalized to those in the CSE or TGSE sequences by high dose administration of the iron colloid preparation. We think perhaps that the imaging ability for hepatocellular carcinoma, similar to that of superparamagnetic contrast media, can be obtained with paramagnetic CSIC by administering it at a higher dose.
鳥取大学の論文